Products
Capreomycin
Pharmacotherapeutic group
Antibiotic agentInternational name
CapreomycinDosage form
Powder for solution for intravenous and intramuscular administrationPolypeptide antibiotic produced by Streptomyces capreolus (with a MIC of 1.25-2.5 mg/L in a liquid medium). It inhibits protein synthesis in a bacterial cell and has a bacteriostatic effect. It is effective against Mycobacterium tuberculosis only. When used as monotherapy, it quickly induces emergence of resistant strains and has a complete cross resistance with viomycin and partial cross resistance with aminoglycosides.